DOCSLIB.ORG

Tert-Butanol - Isobutanol

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Tert-Butanol - Isobutanol Environmental Health Criteria 65 BUTANOLS: FOUR ISOMERS - 1-Butanol - 2-Butanol - tert-Butanol - Isobutanol Please note that the layout and pagination of this web version are not identical with the printed version. Butanols - four isomers (EHC 65, 1987) INTERNATIONAL PROGRAMME ON CHEMICAL SAFETY ENVIRONMENTAL HEALTH CRITERIA 65 BUTANOLS: FOUR ISOMERS - 1-Butanol - 2-Butanol - tert-Butanol - Isobutanol This report contains the collective views of an international group of experts and does not necessarily represent the decisions or the stated policy of the United Nations Environment Programme, the International Labour Organisation, or the World Health Organization. Published under the joint sponsorship of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization World Health Orgnization Geneva, 1987 The International Programme on Chemical Safety (IPCS) is a joint venture of the United Nations Environment Programme, the International Labour Organisation, and the World Health Organization. The main objective of the IPCS is to carry out and disseminate evaluations of the effects of chemicals on human health and the quality of the environment. Supporting activities include the development of epidemiological, experimental laboratory, and risk-assessment methods that could produce internationally comparable results, and the development of manpower in the field of toxicology. Other activities carried out by the IPCS include the development of know-how for coping with chemical accidents, coordination of laboratory testing and epidemiological studies, and promotion of research on the mechanisms of the biological action of chemicals. ISBN 92 4 154265 9 The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. Page 1 of 75 Butanols - four isomers (EHC 65, 1987) (c) World Health Organization 1987 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. CONTENTS ENVIRONMENTAL HEALTH CRITERIA FOR BUTANOLS - FOUR ISOMERS: 1-BUTANOL, 2-BUTANOL, tert-BUTANOL, ISOBUTANOL INTRODUCTION 1-BUTANOL 2-BUTANOL tert-BUTANOL ISOBUTANOL REFERENCES WHO TASK GROUP MEETING ON ENVIRONMENTAL HEALTH CRITERIA FOR BUTANOLS - FOUR ISOMERS: 1-BUTANOL, 2-BUTANOL, tert-BUTANOL, ISOBUTANOL Members Dr B.B. Chatterjee, Calcutta, India Dr S. Dobson, Institute of Terrestrial Ecology, Monks Wood Experimental Station, Abbots Ripton, Huntingdon, United Kingdom (Rapporteur) Dr R. Drew, Department of Clinical Pharmacology, Flinders University of South Australia, Bedford Park, South Australia, Australia (Chairman) Dr M.-S. Galina Avilova, Institute of Occupational Hygiene and Professional Diseases, Moscow, USSR Dr A.A.E. Massoud, Department of Community, Environmental and Occupational Medicine, Faculty of Medicine, Ain-Shams University, Abbasia, Cairo, Egypt (Vice-Chairman) Dr A.N. Mohammed, University of Calabar, Calabar, Nigeria Page 2 of 75 Butanols - four isomers (EHC 65, 1987) Dr C.P. Sadarangani, Bader Al Mulla and Brothers, Safat, Kuwait Secretariat Ms B. Bender, International Register of Potentially Toxic Chemicals, United Nations Environment Programme, Geneva, Switzerland Dr K.W. Jager, International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland (Secretary) Ms F. Ouane, International Register of Potentially Toxic Chemicals, United Nations Environment Programme, Geneva, Switzerland NOTE TO READERS OF THE CRITERIA DOCUMENTS Every effort has been made to present information in the criteria documents as accurately as possible without unduly delaying their publication. In the interest of all users of the environmental health criteria documents, readers are kindly requested to communicate any errors that may have occurred to the Manager of the International Programme on Chemical Safety, World Health Organization, Geneva, Switzerland, in order that they may be included in corrigenda, which will appear in subsequent volumes. * * * Detailed data profiles and legal files can be obtained from the International Register of Potentially Toxic Chemicals, Palais des Nations, 1211 Geneva 10, Switzerland (Telephone no. 988400 - 985850). ENVIRONMENTAL HEALTH CRITERIA FOR BUTANOLS - FOUR ISOMERS: 1-BUTANOL, 2-BUTANOL, tert-BUTANOL, ISOBUTANOL A WHO Task Group on Environmental Health Criteria for Butanols met in Geneva from 11 to 15 November 1985. Dr K.W. Jager opened the meeting on behalf of the Director-General. The Task Group reviewed and revised the draft criteria document and made an evaluation of the health risks of exposure to butanols. The first draft of this document was partially based on information contained in Toxicology Data Sheets made available by the Health, Safety and Environment Division of Shell Internationale Petroleum Maatschappij B.V., and on information obtained by a search of data bases by IRPTC. Additional information supplied by IPCS Participating Institutions was added to the second draft. The efforts of all who helped in the preparation and finalization of the document are gratefully acknowledged. * * * Partial financial support for the publication of this criteria document was kindly provided by the United States Department of Health and Human Services, through a contract from the National Institute of Environmental Health Sciences, Research Triangle Park, Page 3 of 75 Butanols - four isomers (EHC 65, 1987) North Carolina, USA - a WHO Collaborating Centre for Environmental Health Effects. The United Kingdom Department of Health and Social Security generously covered the costs of printing. INTRODUCTION The butanol isomers occur naturally as products of fermentation and are also synthesized from petrochemicals. They are used widely as solvents and intermediates in chemical industries. Human exposure to high concentrations of the butanol isomers will be primarily occupational while exposure to low concentrations will be mainly through foods in which they occur naturally or as flavouring agents. Apart from slight differences in the boiling point and water solubility, the physical properties of the isomers are similar. With only minor differences between isomers, the toxicity for aquatic organisms of all four butanols is low and none of the compounds shows any capacity for bioaccumulation. Apart from tert-butanol, all isomers are readily biodegradable and would be expected to be fully oxidised by microorganisms within a few days. The tert-butanol is metabolized more slowly and would be degraded within a few weeks. The likely background concentrations of all butanol isomers would not have any impact on the aquatic environment. In animals, the butanols are readily absorbed through the lungs and gastrointestinal tract. 1-Butanol, 2-butanol, and isobutanol are primarily metabolized by alcohol dehydrogenase and are rapidly eliminated from the blood. tert-Butanol is not a substrate for alcohol dehydrogenase and its elimination is slower than that of the other isomers. On the basis of oral LD50 values in the rat, the butanols can be classified as being slightly or practically non-toxic. In large amounts, all isomers have the ability to induce signs of alcoholic intoxication in both animals and man. Data regarding other biological effects in man and animals cannot be easily compared and symptoms and effects are covered in the separate sections for each isomer. On the basis of the available data, the Task Group did not expect any adverse effects from occupational exposure under conditions of good manufacturing practice. The Task Group considered that the available data were inadequate to give guidelines for the setting of occupational exposure limits for any of the butanol isomers. The effects of long-term exposure to low concentrations of the butanols could not be judged because of lack of information. The Task Group recommended that relevant studies should be conducted so that this could be achieved. ENVIRONMENTAL HEALTH CRITERIA FOR 1-BUTANOL Page 4 of 75 Butanols - four isomers (EHC 65, 1987) CONTENTS ENVIRONMENTAL HEALTH CRITERIA FOR 1-BUTANOL 1. SUMMARY 2. IDENTITY, PHYSICAL AND CHEMICAL PROPERTIES, ANALYTICAL METHODS 2.1 Identity 2.2 Physical and chemical properties 2.3 Analytical methods 3. SOURCES OF HUMAN AND ENVIRONMENTAL EXPOSURE 4. ENVIRONMENTAL TRANSPORT, DISTRIBUTION, AND TRANSFORMATION 5. ENVIRONMENTAL LEVELS AND HUMAN EXPOSURE 6. KINETICS AND METABOLISM 7. EFFECTS ON ORGANISMS IN THE ENVIRONMENT 7.1 Aquatic organisms
Load more

Recommended publications
  • Alcohols Combined 1405
    ALCOHOLS COMBINED 1405 Formulas: Table 1 MW: Table 1 CAS: Table 2 RTECS: Table 2 METHOD: 1405, Issue 1 EVALUATION: PARTIAL Issue 1: 15 March 2003 OSHA : Table 2 PROPERTIES: Table 1 NIOSH: Table 2 ACGIH: Table 2 COMPOUNDS: (1) n-butyl alcohol (4) n-propyl alcohol (7) cyclohexanol (2) sec-butyl alcohol (5) allyl alcohol (8) isoamyl alcohol (3) isobutyl alcohol (6) diacetone alcohol (9) methyl isobutyl carbinol SYNONYMS: See Table 3. SAMPLING MEASUREMENT SAMPLER: SOLID SORBENT TUBE TECHNIQUE: GAS CHROMATOGRAPHY, FID (Coconut shell charcoal, 100 mg/50 mg) ANALYTE: Compounds above FLOW RATE: 0.01 to 0.2 L/min DESORPTION: 1 mL 5% 2-propanol in CS2 Compounds: (1-3 ) (4-9) VOL-MIN: 2 L 1 L INJECTION -MAX: 10 L 10 L VOLUME: 1 µL SHIPMENT: Routine TEMPERATURE -INJECTION: 220 °C SAMPLE -DETECTOR: 250 - 300 °C STABILITY: See Evaluation of Method. -COLUMN: 35 °C (7 minutes), to 60 °C at 5 °C/minute, hold 5 minutes, up to BLANKS: 2 to 10 field blanks per set 120 °C at 10 °C /minute, hold 3 minutes. CARRIER GAS: He, 4 mL/min ACCURACY COLUMN: Capillary, fused silica, 30 m x 0.32-mm RANGE STUDIED: Not studied [1, 2]. ID; 0.5 µm film polyethylene glycol, DB- wax or equivalent BIAS: Not determined CALIBRATION: Solutions of analyte in eluent (internal OVERALL standard optional) PRECISION (Ö ): Not determined rT RANGE: See EVALUATION OF METHOD. ACCURACY: Not determined ESTIMATED LOD: 1 µg each analyte per sample PRECISION: See EVALUATION OF METHOD. APPLICABILITY: This method may be used to determine two or more of the specified analytes simultaneously.
    [Show full text]
  • Short Chain Fatty Acid Profile Service Code: SCFA
    Short Chain Fatty Acid Profile Service Code: SCFA Summary: Cold extraction of short chain fatty acids, measured by EI- GCMS without derivatization. SCFA species are reported as uM, with CV's generally ~10%. Container: Eppendorf Tube or equivalent Normal Volume: Plasma (100 ul); Tissue (50-100 mgs); Cells (2E7), Feces (50 mg) Minimal Volume: Plasma (50 uL); Tissue (30 mg); Cells (~5E6); Feces (40 mg) Special Handling: If human or primate, note any known presence of infectious agents. Sample Collection: Snap freeze by liquid nitrogen. For tissues, resect and snap-freeze as soon as practical in tared centrifuge tube. Provide both sample weight and tared vial weight on sample submission Reference: Table I: Analytes reported. Others on special request: Analyte Abbr. PubCHEM LOQ(uM) Acetic acid (C2:0) 176 Propionic acid (C3:0) 1032 Butyric acid (C4:0) 264 Isobutyric acid (C4:0i) 6590 Valeric acid (C5:0) 7991 Isovaleric acid (C5:0i) 10430 Caproic acid (Hexanoic) (C6:0) 8892 Heptanoic acid (C7:0) 8094 Caprylic acid (Octanoic) (C8:0) 379 Nonanoic acid (C9:0) 8158 Table II: Internal standards and corresponding analytes Internal Standards Source Cat# Analytes quantified mM Sigma 488399 Butyric, Isobutyric, Valeric, Isovaleric 4 Butyric-d7 acid Acids Acetic-d3 acid Sigma 487856 Acetic, propionic Acids 4 Caproic, Heptanoic, Caprylic, 4 Hexanoic-d11 acid Sigma 448168 Nonanoic Acids Materials 1. Agilent 6890 with 5973 MSD, autosampler 2. Vortexer 3. Refrigerated centrifuge, capable of 13,000g with eppendorf tube compatible rotor 4. ice bucket, ice 5. Balance 6. Prepared stock solutions of short chain fatty acid standards and isotope-labeled short chain fatty acid internal standards.
    [Show full text]
  • Federal Register/Vol. 81, No. 250/Thursday, December 29, 2016
    95886 Federal Register / Vol. 81, No. 250 / Thursday, December 29, 2016 / Rules and Regulations C. Regulatory Flexibility Act (RFA) I. National Technology Transfer and ENVIRONMENTAL PROTECTION Advancement Act (NTTAA) AGENCY This action is not subject to the RFA. This rulemaking does not involve The RFA applies only to rules subject to 40 CFR Part 180 notice-and-comment rulemaking technical standards. requirements under the APA, 5 U.S.C. [EPA–HQ–OPP–2016–0007 and EPA–HQ– J. Executive Order 12898: Federal OPP–2016–0008; FRL–9950–40] 553, or any other statute. This rule is not Actions To Address Environmental subject to notice-and-comment Justice in Minority Populations and Isobutyl Acetate and Isobutyric Acid; requirements because the agency has Low-Income Populations Exemption From the Requirement of a invoked the APA ‘‘good cause’’ The EPA believes that this action is Tolerance exemption under 5 U.S.C. 553(b). not subject to Executive Order 12898 (59 AGENCY: Environmental Protection FR 7629, February 16, 1994) because it D. Unfunded Mandates Reform Act Agency (EPA). (UMRA) does not establish an environmental health or safety standard. This good ACTION: Final rule. This action does not contain any cause final action simply extends the SUMMARY: This regulation establishes unfunded mandate of $100 million or date for the EPA to take action on a more as described in UMRA, 2 U.S.C. exemptions from the requirement of a petition and does not have any impact tolerance for residues of isobutyl acetate 1531–1538, and does not significantly or on human health or the environment.
    [Show full text]
  • Supporting Information
    Supporting Information Section 1 Components of DCM based coating strippers Table 1. Composition of Klean Strip Premium. CAS # Components Concentration 75-09-2 Dichloromethane 70.0-95.0% 67-56-1 Methanol < 5.0% 127087-87-0 Poly(oxy-1,2-ethandiyl) < 5.0% 124-38-9 Carbon dioxide < 5.0% Table 2. Composition of Klean Strip X. CAS # Components Concentration 75-09-2 Dichloromethane 30.0 – 40.0% 67-56-1 Methanol 15.0 – 26.0% 67-64-1 Acetone < 10.0% 1330-20-7 Xylene < 10.0% 108-88-3 Toluene < 10.0% 100-41-4 Ethylbenzene < 5.0% 64-17-5 Ethyl alcohol < 5.0% 67-63-0 Isopropyl alcohol < 5.0% Section 2 Sample preparation for the dwell time test As Figure S1 shows, a gasket was pasted on the conformal coating surface and a sheet of parafilm attached to the back of the printed circuit board to avoid solvent leakage dur- ing the dwell test. Figure 1. Sample preparation for the dwell time test. Section 3 Thickness measurement of coated PCBs Materials and Equipment Printed circuit boards (PCB), acrylic conformal coating, tape, Dektak stylus profiler (Bruker, Arizona, USA). Methods A piece of tape was attached on a PCB before coating. The coating was applied on the PCB using the same method as dip coating in the dwell time test. The PCB was sta- tioned and dried at room temperature for over 24 hours. The tape was then torn out to create a coating step. The PCB was fixed on the detection table using tapes. The stylus scanned from sub- strate to coated area.
    [Show full text]
  • SAFETY DATA SHEET Isopropyl Alcohol
    SAFETY DATA SHEET Isopropyl Alcohol Section 1. Identification GHS product identifier : Isopropyl Alcohol Chemical name : Isopropyl alcohol Other means of : isopropanol; 2-Propanol identification Product type : Liquid. Product use : Synthetic/Analytical chemistry. Synonym : isopropanol; 2-Propanol SDS # : 001105 Supplier's details : Airgas USA, LLC and its affiliates 259 North Radnor-Chester Road Suite 100 Radnor, PA 19087-5283 1-610-687-5253 24-hour telephone : 1-866-734-3438 Section 2. Hazards identification OSHA/HCS status : This material is considered hazardous by the OSHA Hazard Communication Standard (29 CFR 1910.1200). Classification of the : FLAMMABLE LIQUIDS - Category 2 substance or mixture EYE IRRITATION - Category 2A SPECIFIC TARGET ORGAN TOXICITY (SINGLE EXPOSURE) (Narcotic effects) - Category 3 GHS label elements Hazard pictograms : Signal word : Danger Hazard statements : May form explosive mixtures with air. Highly flammable liquid and vapor. Causes serious eye irritation. May cause drowsiness or dizziness. Precautionary statements General : Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand. Prevention : Wear protective gloves. Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking. Use explosion- proof electrical, ventilating, lighting and all material-handling equipment. Use only non- sparking tools. Take precautionary measures against static discharge. Keep container tightly closed. Use only outdoors or in a well-ventilated area. Avoid breathing vapor. Wash hands thoroughly after handling. Response : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER or physician if you feel unwell.
    [Show full text]
  • [Agr. Biol. Chem., Vol. 36, No. 1, P. 112---119, 1972] Studies of the Peptide Antibiotic Suzukacillin Part II by Takaaki OOKA An
    [Agr. Biol. Chem., Vol. 36, No. 1, p. 112---119,1972] Studies of the Peptide Antibiotic Suzukacillin Part II By Takaaki OOKA and Isao TAKEDA TechnicalResearch Laboratory, Asahi ChemicalIndustry Co., Ltd., Nakadai-cho3-27, Itabashi-kuTokyo ReceivedJuly 26, 1971 Suzukacillin produced by Trichoderma viride 6301 strain was purified and shown to be separated into two components A and B on thin-layer chromatography. The component A was isolated and crystallized from the mixture of components by alumina column chro matography. The component A is composed of six amino acids, Gly, Glu, Ala, Pro, Val, Leu and an unknown amino acid. This unknown amino acid was identified as a-amino isobutyric acid. It is supposed that a-amino isobutyrie acid is biosynthesized mainly from L-valine by the isotopic experiments. Suzukacillin formation by Trichoderma viride 6301 was stimulated by the addition of L-Asn, GABA, L-Ser, Gly and L-Arg into the medium. Trichoderma viride 6301 strain producing Suzu ments were purchased as reagents from Tokyo Kasei kacillin was isolated by the author's laboratory. Co., Ltd. The following radioactive compounds were This organism accumulated noted amount of surplied by Dai-ichi Chemical Co., Ltd., with the in the peptide antibiotic. It was detected on dicated specific activities (ƒÊCi per mmole): Starch- TLC that the peptide antibiotic Suzukacillin (U)14C (30.8), pyruvic acid-(U)-14C (31.5), glycine- consists of two components A and B. A is (U)14C (45.2), L-alanine-(U)-14C (107), L-glutamic acid- (U)-14C (165), L-proline-(U)-14C (165), L-valine-(U)-14C a major and B is a minor component.
    [Show full text]
  • Enhanced Butanol Production by Free and Immobilized Clostridium Sp
    Enhanced Butanol Production by Free and Immobilized Clostridium sp. Cells Using Butyric Acid as Co-Substrate Laili Gholizadeh This thesis comprises 30 ECTS credits and is a compulsory part in the Master of Science with a Major in Chemical Engineering – Applied Biotechnology 120 ECTS credits No. 10/2009 Title: Enhanced Butanol Production by Free and Immobilized Clostridium sp. Cells using Butyric Acid as Co-Substrate. Author: Laili Gholizadeh Baroghi (e-mail: [email protected]) Master Thesis Subject Category: Biotechnology (Bioprocess Engineering – Biofuels) University College of Borås School of Engineering SE-501 90 BORÅS Telephone: (+46) 033 435 4640 Examiner: Prof. Mohammad Taherzadeh Supervisor and Thesis Advisor: Prof. Shang–Tian Yang Supervisor Address: OSU–Ohio State University 125 Koffolt Laboratories 140 West 19th Ave. Columbus, OH 43210–1185, USA Client: Ohio State University (OSU), Chemical & Biomolecular Engineering Department Prof. Shang–Tian Yang Columbus, Ohio; USA. Date: 08–12–2009 Keywords: Bio-butanol y Acetone–Butanol–Ethanol (ABE) y ABE- fermentation y Butyric acid y Clostridium y C. acetobutylicum ATCC 824 y C. beijerinckii ATCC 55025 y C. beijerinckii BA 101 y C. beijerinckii NCIMB 8052 y Fibrous-bed Bioreactor (FBB) y Batch y Suspended cell culture y Immobilized cell system. DEDICATION I would like to dedicate this M.Sc. Thesis to my beloved Family for all their love and encouragement and for always been supportive of my choices. “I am among those who think that science has great beauty. A scientist in his laboratory is not only a technician: he is also a child placed before natural phenomena, which impress him like a fairy tale.” − Marie Curie ABSTRACT Butanol production by four different Clostridium sp.
    [Show full text]
  • Clinical Trial of the Neuroprotectant Clomethiazole in Coronary Artery Bypass Graft Surgery a Randomized Controlled Trial Robert S
    Anesthesiology 2002; 97:585–91 © 2002 American Society of Anesthesiologists, Inc. Lippincott Williams & Wilkins, Inc. Clinical Trial of the Neuroprotectant Clomethiazole in Coronary Artery Bypass Graft Surgery A Randomized Controlled Trial Robert S. Kong, F.R.C.A.,* John Butterworth, M.D.,† Wynne Aveling, F.R.C.A.,‡ David A. Stump, M.D.,† Michael J. G. Harrison, F.R.C.P.,§ John Hammon, M.D.,ʈ Jan Stygall, M.Sc.,# Kashemi D. Rorie, Ph.D.,** Stanton P. Newman, D.Phil.†† Background: The neuroprotective property of clomethiazole THE efficacy of coronary artery bypass surgery in the has been demonstrated in several animal models of global and relief of angina and in some circumstances in enhancing Downloaded from http://pubs.asahq.org/anesthesiology/article-pdf/97/3/585/335909/0000542-200209000-00011.pdf by guest on 29 September 2021 focal brain ischemia. In this study the authors investigated the life expectation is now accepted. It is a tribute to the low effect of clomethiazole on cerebral outcome in patients under- mortality of the procedure that interest is now focused going coronary artery bypass surgery. Methods: Two hundred forty-five patients scheduled for on the neurologic and neuropsychological complica- 1–3 coronary artery bypass surgery were recruited at two centers tions. Adverse neurologic outcomes have been found and prospectively randomized to clomethiazole edisilate to occur in 2–6% of patients and neuropsychological (0.8%), 225 ml (1.8 mg) loading dose followed by a maintenance deficits in 10–30%.4–6 These complications are consid- dose of 100 ml/h (0.8 mg/h) during surgery, or 0.9% NaCl ered to be ischemic in nature, being a consequence of (placebo) in a double-blind trial.
    [Show full text]
  • Transcription 12.01.12
    Lecture 2B • 01/12/12 We covered three different reactions for converting alcohols into leaving groups. One was to turn an alcohol into an alkyl chloride, that was using thionyl chloride. Second reaction was using tosyl chloride; the primary difference between those two reactions is one of stereochemistry. An inversion of stereochemistry does occur if you use thionyl chloride, because it does affect the carbon-oxygen bond, but because forming a tosylate does not touch the carbon-oxygen bond, only the oxygen- hydrogen bond, there’s no change in stereochemistry there. We then saw phosphorus tribromide that reacts very similarly to the thionyl chloride; you get an alkyl bromide instead, but it also has inversion of configuration. The last reaction is not a new mechanism, it is just an Sn2 reaction, it’s called the Finkelstein reaction. Really this works, in a sense, off of Le Châtelier’s principle. In solution, in theory, sodium iodide can displace bromide, but sodium bromide can displace iodide, so you can have an Sn2 reaction that goes back and forth and back and forth and back and forth. Except, sodium iodide is somewhat soluble in acetone, while sodium chloride and sodium bromide are not. So, in fact, one of the things that we get out of this as a by-product is sodium bromide, which, again, is not soluble in acetone and therefore precipitates out and is no longer part of the reaction mixture, so there’s no reverse reaction possible. Because of this solubility trick, it allows this reaction to be pulled forward, which means you can get the alkyl iodide.
    [Show full text]
  • Isobutanol in Marine Gasoline
    Isobutanol in Marine Gasoline Glenn Johnston July 11, 2017 Bioeconomy 2017 Washington D.C. 1B: Drivers for Emergence of Biofuels for Maritime Industry © 2012 Gevo, Inc. | 1 Gevo’s Current Business System Gevo Production Facilities Core Near Term Markets Isobutanol Production – Side-by-Side with Ethanol Drop-in Markets - Isobutanol Luverne, MN Isobutanol Specialty Chemicals & Solvents Specialty Gasoline Blendstock (Marine/Off-Road) 15 MGPY EtOH 1.5 MGPY IBA* Isobutanol Hydrocarbon Biorefinery Drop-in Markets - Hydrocarbons South Hydrocarbons Hampton Jet Fuel Resources Silsbee, TX Isooctane (gasoline) © 2016 Gevo, Inc. | 2 Isobutanol Properties Gasoline blending value Gasoline Ethanol Isobutanol RON 95 109 105 MON 85 90 91 Anti-knock Index 90 100 98 RVP (psi) 7-15 19 5.2 Density 20C [kg/m3] 720-775 794 801 Boiling Point (C) 32.2 21.1 26.6 % Heating Value of Gasoline 100 66 84 Oxygen (%w/w) <2.7% 34.7 21.6 isobutanol has low RVP, enabling refiners to blend incremental volumes of butanes and pentanes Marine Research Overview Marine Engine Tested – BRP Envinrude and SeaDoo, Mercury, Volvo-Penta, Yamaha, Tohatsu, Indmar, OMC-Johnson, Honda. Marine Biobutanol over 5 years of research -Alternative Fuel Butanol: Preliminary Investigation on Performance and Emissions of a Marine Two-Stroke Direct Fuel Injection Engine -Impact of Blending Gasoline with lsobutanol Compared to Ethanol on Efficiency, Performance and Emissions of a Recreational Marine 4-Stroke Engine -Gaseous and Particulate Emissions Using Isobutanol-Extended Fuel in Recreational Marine
    [Show full text]
  • Aldehydes and Ketones
    Organic Lecture Series Aldehydes And Ketones Chap 16 111 Organic Lecture Series IUPAC names • the parent alkane is the longest chain that contains the carbonyl group • for ketones, change the suffix -e to -one • number the chain to give C=O the smaller number • the IUPAC retains the common names acetone, acetophenone, and benzophenone O O O O Propanone Acetophenone Benzophenone 1-Phenyl-1-pentanone (Acetone) Commit to memory 222 Organic Lecture Series Common Names – for an aldehyde , the common name is derived from the common name of the corresponding carboxylic acid O O O O HCH HCOH CH3 CH CH3 COH Formaldehyde Formic acid Acetaldehyde Acetic acid – for a ketone , name the two alkyl or aryl groups bonded to the carbonyl carbon and add the word ketone O O O Ethyl isopropyl ketone Diethyl ketone Dicyclohexyl ketone 333 Organic Lecture Series Drawing Mechanisms • Use double-barbed arrows to indicate the flow of pairs of e - • Draw the arrow from higher e - density to lower e - density i.e. from the nucleophile to the electrophile • Removing e - density from an atom will create a formal + charge • Adding e - density to an atom will create a formal - charge • Proton transfer is fast (kinetics) and usually reversible 444 Organic Lecture Series Reaction Themes One of the most common reaction themes of a carbonyl group is addition of a nucleophile to form a tetrahedral carbonyl addition compound (intermediate). - R O Nu - + C O Nu C R R R Tetrahedral carbonyl addition compound 555 Reaction Themes Organic Lecture Series A second common theme is
    [Show full text]
  • A Retrospective Comparison of Inappropriate Prescribing Of
    Schjøtt and Aßmus BMC Medical Informatics and Decision Making (2019) 19:102 https://doi.org/10.1186/s12911-019-0821-0 RESEARCHARTICLE Open Access A retrospective comparison of inappropriate prescribing of psychotropics in three Norwegian nursing homes in 2000 and 2016 with prescribing quality indicators Jan Schjøtt1,2* and Jörg Aßmus3 Abstract Background: Inappropriate prescribing of psychotropics is a persistent and prevalent problem in nursing homes. The present study compared inappropriate prescribing of psychotropics in nursing homes 16 years apart with prescribing quality indicators. The purpose was to identify any change in inappropriate prescribing of relevance for medical informatics. Methods: Three Norwegian nursing homes were audited in 2000 and 2016 with regard to prescribing quality. Psychotropics among 386 patients in 2000, and 416 patients in 2016, included combinations of antidepressants, antipsychotics, anxiolytics-hypnotics, and antiepileptics. Prescribing quality indicators included psychotropic polypharmacy (defined as concurrent use of three or more psychotropics) and potential inappropriate psychotropic substances or combinations. Furthermore, potential clinically relevant psychotropic interactions were classified as pharmacodynamic or pharmacokinetic using an interaction database. The first ranked (most important) interaction in each patient was selected with the following importance of categories in the database; recommended action > documentation > severity. Three levels (from low to high) within each category were used for ranking. Results: From 2000 to 2016, psychotropic polypharmacy increased from 6.2 to 29.6%, potential inappropriate psychotropic substances was reduced from 17.9 to 11.3% and potential inappropriate psychotropic combinations increased from 7.8 to 27.9%. Changes in polypharmacy and combinations were predominantly associated with prescribing of anxiolytics-hypnotics.
    [Show full text]